Selected Papers from The 1st International Online Conference by Antibodies 2025
A special issue of Antibodies (ISSN 2073-4468).
Deadline for manuscript submissions: 28 February 2026 | Viewed by 24
Special Issue Editor
Interests: alternative scaffolds; antibody engineering; antibody humanization; anticalins; protein pharmacology; protein design; protein crystallography
Special Issue Information
Dear Colleagues,
We are delighted to announce a Special Issue inspired by the 1st International Online Conference by Antibodies "Therapeutic Antibodies: New Trends in Discovery, Developability and Characterization" (13–14 October 2025), an online conference focused on the latest developments in antibody research, with emphasis on applications in medical therapy. This Special Issue will serve as a multidisciplinary platform for the publication of cutting-edge research and advancements in antibody discovery and development.
Scope and Topics
This Special Issue will cover a broad range of topics discussed during the conference:
- Antibody Discovery and Engineering
- Antibody-based Therapeutics
- Immuno-oncology and Tumor Imaging
- Humoral Immunity
- Computational Antibody Engineering
Prof. Dr. Arne Skerra
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Antibodies is an international peer-reviewed open access quarterly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1800 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- antibody engineering
- antibod-drug conjugate
- computational design
- immunooncology
- tumor Imaging
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
